Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 120,495 | 127,665 | 135,551 | 66,329 | 77,617 |
| Marketable Securities | 251,657 | 255,669 | 232,670 | 365,343 | 145,918 |
| Receivables | 59,786 | 53,976 | 41,123 | 31,057 | 27,625 |
| Inventories | 12,868 | 12,412 | 7,730 | 6,100 | 4,988 |
| Other current assets | 0 | 0 | 14,000 | 14,000 | 0 |
| TOTAL | $485,464 | $471,602 | $458,636 | $499,253 | $266,463 |
| Non-Current Assets | |||||
| PPE Net | 1,890 | 2,689 | 195 | 633 | 1,002 |
| Investments And Advances | 160,270 | 219,831 | 57,176 | 4,947 | 112,277 |
| Other Non-Current Assets | 189,027 | 146,431 | 105,510 | 78,597 | 44,014 |
| TOTAL | $351,187 | $368,951 | $162,881 | $84,177 | $157,293 |
| Total Assets | $836,651 | $840,553 | $621,517 | $583,430 | $423,756 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 40,444 | 15,376 | 17,396 | 11,976 | 6,908 |
| Accrued Expenses | 33,954 | 33,868 | 72,958 | 28,573 | 40,107 |
| Other current liabilities | N/A | N/A | 14,000 | N/A | N/A |
| TOTAL | $166,085 | $140,773 | $104,505 | $72,491 | $47,541 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,562 | 0 | 0 | 0 | 0 |
| TOTAL | $22,761 | $20,191 | $10,307 | $9,097 | $409 |
| Total Liabilities | $188,846 | $160,964 | $114,812 | $81,588 | $47,950 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 106,374 | 105,503 | 103,517 | 107,899 | 105,962 |
| Common Shares | 140 | 136 | 133 | 131 | 127 |
| Retained earnings | 643,387 | 543,735 | 402,526 | 296,386 | 194,968 |
| Other shareholders' equity | 2,678 | -390 | 531 | -1,017 | -638 |
| TOTAL | $647,805 | $679,589 | $506,705 | $501,842 | $375,806 |
| Total Liabilities And Equity | $836,651 | $840,553 | $621,517 | $583,430 | $423,756 |